Vcanbio Cell & Gene Engineering Corp (600645.SS) Stock Price
Vcanbio Cell & Gene Engineering Corp Price
Revenue has compounded at 6.9% per year over the past 19 years to 1.45 B CNY. Earnings per share have grown at 13.1% per year over the last 19 years. Vcanbio Cell & Gene Engineering Corp's net margin stands at 7.8%, down from 10.1% several years earlier.
Vcanbio Cell & Gene Engineering Corp stock price
Vcanbio Cell & Gene Engineering Corp business model & stock analysis
Frequently asked questions about Vcanbio Cell & Gene Engineering Corp
5 analysts currently rate the Vcanbio Cell & Gene Engineering Corp stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Vcanbio Cell & Gene Engineering Corp to generate revenue of 1.88 B CNY and earnings per share of 0.39 CNY.
Vcanbio Cell & Gene Engineering Corp Analyst Price Targets 2026
Converted at the current exchange rate, the Vcanbio Cell & Gene Engineering Corp share trades at 2.47 EUR (18.53 CNY).
The Vcanbio Cell & Gene Engineering Corp share (600645.SS) is listed on 1 stock exchanges, including: Shanghai (600645.SS).
The expected revenue of Vcanbio Cell & Gene Engineering Corp is 1.88 B CNY. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Vcanbio Cell & Gene Engineering Corp is 177.90 M CNY. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Vcanbio Cell & Gene Engineering Corp is currently 47.49. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Vcanbio Cell & Gene Engineering Corp stock.
The price-to-sales ratio (P/S) of Vcanbio Cell & Gene Engineering Corp is currently 4.48. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Vcanbio Cell & Gene Engineering Corp stock.
The Eulerpool Quality Score for Vcanbio Cell & Gene Engineering Corp is 3/10.
The ISIN of Vcanbio Cell & Gene Engineering Corp is CNE000000545. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Vcanbio Cell & Gene Engineering Corp is 600645.SS. The ticker symbol is used to trade Vcanbio Cell & Gene Engineering Corp shares on the stock exchange.
Vcanbio Cell & Gene Engineering Corp stock
Vcanbio Cell & Gene Engineering Corp Peer Group
Vcanbio Cell & Gene Engineering Corp Ticker
Vcanbio Cell & Gene Engineering Corp FIGI
All fundamentals and in-depth analysis of Vcanbio Cell & Gene Engineering Corp
Our stock analysis for Vcanbio Cell & Gene Engineering Corp stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Vcanbio Cell & Gene Engineering Corp. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.